Friday 20th April 2012
It is important for all NHS organisations to be aware of and plan for the managed entry of new medicines. This session will explore how horizon scanning for new medicines is undertaken and how the impact on the NHS is assessed. How such information is utilised in the NHS together with factors that influence which drugs should be highlighted for active management will also be discussed. Some of the barriers and challenges of this process with be explored.
Assistant Director, North West Medicines Information Centre, Pharmacy Practice Unit, Liverpool
Helen has over 14 years experience in horizon scanning for the NHS and is the executive editor of the UKMi horizon scanning document Prescribing Outlook – New Medicines. She is an advisor to the Department of Health on pipeline drugs that are considered for NHS national tariff exclusion. Helen is currently the assistant director of the North West Medicines Information Centre with experience as a primary care medicines information pharmacist as well as experience in formulary, teaching and clinical posts in secondary care.